• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白酶激活受体2:激活、信号传导与功能

Protease-activated receptor 2: activation, signalling and function.

作者信息

Cottrell G S, Amadesi S, Schmidlin F, Bunnett N

机构信息

Departments of Surgery and Physiology, University of California-San Francisco, 521 Parnassus Avenue, San Francisco, CA 94143-0660, U.S.A.

出版信息

Biochem Soc Trans. 2003 Dec;31(Pt 6):1191-7. doi: 10.1042/bst0311191.

DOI:10.1042/bst0311191
PMID:14641024
Abstract

PARs (protease-activated receptors) are a family of four G-protein-coupled receptors for proteases from the circulation, inflammatory cells and epithelial tissues. This report focuses on PAR(2), which plays an important role in inflammation and pain. Pancreatic (trypsin I and II) and extrapancreatic (trypsin IV) trypsins, mast cell tryptase and coagulation factors VIIa and Xa cleave and activate PAR(2). Proteases cleave PAR(2) to expose a tethered ligand that binds to the cleaved receptor. Despite this irreversible activation, PAR(2) signalling is attenuated by beta-arrestin-mediated desensitization and endocytosis, and by lysosomal targeting and degradation, which requires ubiquitination of PAR(2). beta-Arrestins also act as scaffolds for the assembly of multi-protein signalling complexes that determine the location and function of activated mitogen-activated protein kinases. Observations of PAR(2)-deficient mice support a role for PAR(2) in inflammation, and many of the effects of PAR(2) activators promote inflammation. Inflammation is mediated in part by activation of PAR(2) in the peripheral nervous system, which results in neurogenic inflammation and hyperalgesia.

摘要

蛋白酶激活受体(PARs)是一类由四种G蛋白偶联受体组成的家族,可被循环系统、炎症细胞和上皮组织中的蛋白酶激活。本报告重点关注PAR(2),它在炎症和疼痛中起重要作用。胰腺(胰蛋白酶I和II)和胰腺外(胰蛋白酶IV)的胰蛋白酶、肥大细胞组织蛋白酶以及凝血因子VIIa和Xa可切割并激活PAR(2)。蛋白酶切割PAR(2)以暴露与切割后的受体结合的拴系配体。尽管这种激活是不可逆的,但PAR(2)信号传导可通过β-抑制蛋白介导的脱敏和内吞作用,以及通过溶酶体靶向和降解而减弱,这需要PAR(2)的泛素化。β-抑制蛋白还作为多蛋白信号复合物组装的支架,这些复合物决定了活化的丝裂原活化蛋白激酶的位置和功能。对PAR(2)缺陷小鼠的观察支持PAR(2)在炎症中的作用,并且PAR(2)激活剂的许多作用会促进炎症。炎症部分是由外周神经系统中PAR(2)的激活介导的,这会导致神经源性炎症和痛觉过敏。

相似文献

1
Protease-activated receptor 2: activation, signalling and function.蛋白酶激活受体2:激活、信号传导与功能
Biochem Soc Trans. 2003 Dec;31(Pt 6):1191-7. doi: 10.1042/bst0311191.
2
Trypsin IV or mesotrypsin and p23 cleave protease-activated receptors 1 and 2 to induce inflammation and hyperalgesia.胰蛋白酶IV或中胰蛋白酶以及p23可切割蛋白酶激活受体1和2,从而引发炎症和痛觉过敏。
J Biol Chem. 2007 Sep 7;282(36):26089-100. doi: 10.1074/jbc.M703840200. Epub 2007 Jul 10.
3
Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.中性粒细胞弹性蛋白酶激活蛋白酶激活受体-2(PAR2)和瞬时受体电位香草酸受体4(TRPV4),引发炎症和疼痛。
J Biol Chem. 2015 May 29;290(22):13875-87. doi: 10.1074/jbc.M115.642736. Epub 2015 Apr 15.
4
Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4.组织蛋白酶S通过蛋白酶激活受体2(PAR2)和瞬时受体电位香草酸亚型4(TRPV4)的偏向性激动作用引发炎性疼痛。
J Biol Chem. 2014 Sep 26;289(39):27215-27234. doi: 10.1074/jbc.M114.599712. Epub 2014 Aug 12.
5
Protease-activated receptors: the role of cell-surface proteolysis in signalling.蛋白酶激活受体:细胞表面蛋白水解在信号传导中的作用。
Essays Biochem. 2002;38:169-83. doi: 10.1042/bse0380169.
6
Signal transduction by protease-activated receptors.蛋白酶激活受体的信号转导。
Br J Pharmacol. 2010 May;160(2):191-203. doi: 10.1111/j.1476-5381.2010.00705.x.
7
Protease-activated receptors: regulation of neuronal function.蛋白酶激活受体:神经元功能的调节
Neuromolecular Med. 2005;7(1-2):79-99. doi: 10.1385/NMM:7:1-2:079.
8
Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.蛋白酶激活受体:蛋白酶如何向细胞发出信号以引发炎症和疼痛。
Semin Thromb Hemost. 2006 Apr;32 Suppl 1:39-48. doi: 10.1055/s-2006-939553.
9
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.蛋白酶激活受体-2对于因子VIIa和Xa诱导的乳腺癌细胞信号传导、迁移及侵袭至关重要。
Cancer Res. 2006 Jan 1;66(1):307-14. doi: 10.1158/0008-5472.CAN-05-1735.
10
Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2.内体去泛素化酶控制蛋白酶激活受体2的泛素化和下调。
J Biol Chem. 2009 Oct 9;284(41):28453-28466. doi: 10.1074/jbc.M109.025692. Epub 2009 Aug 14.

引用本文的文献

1
PAR2 regulates proliferation, migration of lung cancer and chemotherapy sensitivity by involving PTEN pathway.蛋白酶激活受体2(PAR2)通过磷脂酰肌醇-3,4,5-三磷酸酯酶(PTEN)途径调节肺癌的增殖、迁移及化疗敏感性。
Future Sci OA. 2025 Dec;11(1):2535221. doi: 10.1080/20565623.2025.2535221. Epub 2025 Jul 21.
2
Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine.MEDI0618,一种靶向PAR2的pH依赖性单克隆抗体,在偏头痛临床前模型中的疗效。
Brain. 2025 Apr 3;148(4):1345-1359. doi: 10.1093/brain/awae344.
3
Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2.
在结肠炎期间,蛋白水解细菌的扩增通过 PAR2 外显子的切割放大炎症。
Gut Microbes. 2024 Jan-Dec;16(1):2387857. doi: 10.1080/19490976.2024.2387857. Epub 2024 Aug 22.
4
Inhibition of Protease-Activated Receptor-2 Activation in Parkinson's Disease Using 1-Piperidin Propionic Acid.使用1-哌啶丙酸抑制帕金森病中蛋白酶激活受体-2的激活
Biomedicines. 2024 Jul 22;12(7):1623. doi: 10.3390/biomedicines12071623.
5
The activation fragment of PAR2 is elevated in serum from patients with rheumatoid arthritis and reduced in response to anti-IL6R treatment.PAR2 的激活片段在类风湿关节炎患者的血清中升高,并对抗 IL-6R 治疗有反应降低。
Sci Rep. 2021 Dec 20;11(1):24285. doi: 10.1038/s41598-021-03346-0.
6
Trypsin induces an aversive response in zebrafish by PAR2 activation in keratinocytes.胰蛋白酶通过角质细胞中 PAR2 的激活诱导斑马鱼产生厌恶反应。
PLoS One. 2021 Oct 8;16(10):e0257774. doi: 10.1371/journal.pone.0257774. eCollection 2021.
7
PAR-2-activated secretion by airway gland serous cells: role for CFTR and inhibition by .气道腺泡浆液细胞中 PAR-2 激活的分泌作用:CFTR 的作用及 的抑制作用
Am J Physiol Lung Cell Mol Physiol. 2021 May 1;320(5):L845-L879. doi: 10.1152/ajplung.00411.2020. Epub 2021 Mar 3.
8
Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy.蛋白酶激活受体-2(PAR-2)拮抗剂FSLLRY-NH2作为哮喘辅助治疗的靶向研究。
Medicine (Baltimore). 2020 Oct 23;99(43):e22351. doi: 10.1097/MD.0000000000022351.
9
Polarization of protease-activated receptor 2 (PAR-2) signaling is altered during airway epithelial remodeling and deciliation.气道上皮重塑和纤毛脱落过程中蛋白酶激活受体 2(PAR-2)信号的极化发生改变。
J Biol Chem. 2020 May 8;295(19):6721-6740. doi: 10.1074/jbc.RA120.012710. Epub 2020 Apr 2.
10
Protease-activated receptor 2 activates CRAC-mediated Ca2+ influx to cause prostate smooth muscle contraction.蛋白酶激活受体2激活钙释放激活钙通道(CRAC)介导的钙离子内流,从而引起前列腺平滑肌收缩。
FASEB Bioadv. 2019 Apr;1(4):255-264. doi: 10.1096/fba.2018-00024. Epub 2019 Jan 3.